Skip to main content Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NYSE: ADCT

ADC Therapeutics S.A.

Healthcare | Biotechnology
$1.00 -0.05 (-5.11%) as of 2026-07-14 20:26 UTC
Market Cap$130M
Volume1.28M
EPS (TTM)$-1.12

ADC Therapeutics S.A. (NYSE: ADCT) is a $130M biotechnology company trading at $1.00 (−5.1% today). Figures from SEC EDGAR and market feeds; updated 2026-07-14 20:26 UTC.

52-Week Range
Low $0.78High $4.98
Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.
Key facts
Quote
Price$1.00
Change (1D)-0.05 (-5.11%)
Market cap$130M
Volume1.28M shares
52-week range$0.78 – $4.98
Valuation
EPS (TTM)$-1.12
Returns
52-week return+27.8%
Revenue, margins & earnings
FY2022: net loss $157M on revenue $210M$210MFY2022FY2023: net loss $240M on revenue $70M$70MFY2023FY2024: net loss $158M on revenue $71M$71MFY2024FY2025: net loss $143M on revenue $81M$81MFY2025
  • Net income
  • Taxes & interest
  • Operating costs
  • Net loss year
Annual revenue; bands show net, operating margins · Open in Platform →
SEC Filings SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-07-02
  • 2026-07-02Zaki MohamedChief Medical OfficerA213,900—
  • 2026-07-02GRAHAM PETER JChief Legal OfficerA221,100—
  • 2026-07-02Carmona JoseChief Financial OfficerA203,700—
Sign in to see all transactions →
Top Institutional Holders (latest 13F)
Source: SEC EDGAR · As of 2026-Q1
  • Redmile Group, LLC15,470,502$58.01M-1.2%
  • TCG Crossover Management, LLC11,390,175$42.71M0.0%
  • Prosight Management, LP8,300,000$31.12M-2.1%
View QoQ ownership changes →
Company news View all →
No qualifying company news in the archive. Full tape in the platform →
Questions this page answers

What does ADC Therapeutics S.A. do?

ADC Therapeutics S.A. is a biotechnology company, listed on NYSE as ADCT.

What is ADCT's valuation?

ADCT trades at $1.00, as of 2026-07-14.

When did ADCT last file with the SEC?

ADC Therapeutics S.A.'s most recent SEC filing on record is a 8-K filed 2026-07-02. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings and public market data feeds, fetched 2026-07-14 20:26 UTC. This page is also available as JSON at /api/data?ticker=ADCT and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for ADCT and 3,500+ tickers.

Create a free account — keep ADCT
For your agent
GET /api/data?ticker=ADCT

This page as JSON via rel="alternate" · REST API docs · MCP server (51 tools) · llms.txt